Chemotherapy Plus PD-1 Monoclonal Antibody in the Treatment of Refractory or Relapsed Peripheral T-cell Lymphoma.
Clinical trial NCT05821192 · UNKNOWN
Trial details
- NCT number
- NCT05821192
- Sponsor
- Ou Bai, MD/PHD
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-23
- Primary completion
- 2023-04-18
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.